Ken Mariash Presents Sinaptica Therapeutics at LSI USA '23

Sinaptica has developed a personalized closed-loop noninvasive neuromodulation therapy for Alzheimer’s Disease (AD).
Speakers
Ken Mariash
Ken Mariash
CEO, Sinaptica Therapeutics